Ticker Symbol: ANXNF

Annexin Pharmaceuticals AB

Exchange: US OTC Currency: USD Asset Type: Common Stock

Company Profile

Annexin Pharmaceuticals AB operates as a biotechnology company. It develops treatment of various cardiovascular diseases. The firm establishes and optimizes a cell line for large-scale production of Annexin A5. The company was founded by Anna Frostegård in 2014 and is headquartered in Stockholm, Sweden.

Sector: Health Technology

Industry: Pharmaceuticals: Major

Standard Industrial Classification Code (SIC code): 2834

Address: N/A

Website: http://www.annexinpharma.com

CEO: Jamal El-Mosleh

Tags:

Health Technology
Pharmaceuticals: Major

Pricing

Last Updated: December 31, 1969 07:00 PM EST

Previous Close: -

Change: - ( 0.00%)

Days Range: - - -

Beta: -

52wk. High: -

52wk. Low: -

Ytd. Change 0.00%

50 Day Moving Average: -

200 Day Moving Average: -

Shares Outstanding: 137240061

Valuation

Market Cap: -

PE Ratio: -

EPS (TTM): 0

Dividends

Dividend Per Share (TTM): -

Dividend Yield (TTM): 0.00%

Ex-Dividend Date: N/A